TetraHydroCannabinol.com

  Regular cannabis use leads to fewer diabetes diagnoses in women Texas A&M University has  published  a study indicating that heavy cannabis use in women is associated with lower instances of Diabetes Mellitus, commonly referred to as diabetes.  Statistics published by the charity  Diabetes UK  suggest there are currently approximately 4.5 million people currently living in the UK with a diabetes diagnosis, and a suspected 850,000 who have it but are yet to be diagnosed. A further 13.6 million are thought to be in danger of contracting the condition, mainly through poor lifestyle and diet choices.  Using data collected from t he National Health and Nutrition Examination Survey (NHANES) from 2013 to 2018, researchers estimated the frequency of use and the participant’s self-reported exposure to cannabis. A model of statistical data evaluation was applied to the data to increase the accuracy of the results. The study involved 15,062 participants, 51...

  Researchers recommend clinical trials for CBD to prevent COVID-19 based on promising animal data An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol (CBD), a product of the cannabis plant, can inhibit infection by SARS-CoV-2 in human cells and in mice. The study, published on January 20, 2022, in Science Advances, found that CBD showed a significant negative association with SARS-CoV-2 positive tests in a national sample of medical records of patients taking the FDA-approved drug for treating epilepsy. The researchers now say that clinical trials should be done to determine whether CBD could eventually be used as a preventative or early treatment for COVID-19. They caution, however, that the COVID-blocking effects of CBD come only from a high purity, specially formulated dose taken in specific situations. The study's findings do not suggest that consuming commercially available products with CBD additives that vary in potenc...

  Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol (CBD), a product of the cannabis plant, can inhibit infection by SARS-CoV-2 in human cells and in mice. The study, published on January 20, 2022, in Science Advances, found CBD showed a significant negative association with SARS-CoV-2 positive tests in a national sample of medical records of patients taking the FDA-approved drug for treating epilepsy. The researchers now say that clinical trials should be done to determine whether CBD could eventually be used as a preventative or early treatment for COVID-19. They caution, however, that the COVID-blocking effects of CBD come only from a high purity, specially formulated dose taken in specific situations. The study's findings do not suggest that consuming commercially available products with CBD additives that vary in potency and quality can prevent CO...

  Certain cannabis compounds prevent COVID-19 infection, new study shows A new study has found that certain cannabis compounds prevented the Covid virus from accessing healthy human cells. Some cannabis compounds have been found to prevent the COVID-19 virus from penetrating healthy human cells. The recent laboratory study was published in the Journal of Nature products with research conducted at Oregon State University, led by Richard van Breeman alongside Oregon State’s Global Hemp Innovation Centre. The study suggests that two commonly found compounds in hemp - cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA) - prevent coronavirus from entering cells by blocking a step the pathogen uses to to infect people. In the study, these compounds were able to bind to the spike protein in SARS-CoV-2, which is the same effort used in vaccines and antibody therapy. “That means cell entry inhibitors, like the acids from hemp, could be used to prevent SARS-CoV-2 infection and also...